Medication Use Evaluation of Dronedarone in Comparison to Amiodarone
Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...
Main Authors: | Adam Corey, Nita Johnston |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
University of Minnesota Libraries Publishing
2016-12-01
|
סדרה: | INNOVATIONS in Pharmacy |
נושאים: | |
גישה מקוונת: | https://pubs.lib.umn.edu/index.php/innovations/article/view/480 |
פריטים דומים
-
Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
מאת: Li Y, et al.
יצא לאור: (2023-12-01) -
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
מאת: Mengran Zhang, et al.
יצא לאור: (2021-08-01) -
Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
מאת: Li-Qin Jiang, et al.
יצא לאור: (2016-05-01) -
Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
מאת: Trigo P, et al.
יצא לאור: (2011-12-01) -
Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
מאת: M. Yu. Gilyarov, et al.
יצא לאור: (2010-12-01)